# Intrathecal ziconotide for refractory chronic pain.

> PubMed lists PMID 16849624 in The Annals of pharmacotherapy as Journal Article, Review, with publication-date metadata of 2006-07-18 (day precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-16849624-ziconotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-16849624-ziconotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-16849624-ziconotide-v1.json
- Content SHA-256: `f6b7ee010cde4bca85531f3983881420cd151121ab2baf374d3e15bab69d9318`

## Claims and source pins

### Headline

Intrathecal ziconotide for refractory chronic pain. ([`pubmed-observation-pmid-16849624-2026-01-28-bcb767f52eab`](#source-pubmed-observation-pmid-16849624-2026-01-28-bcb767f52eab))

### Summary

PubMed lists PMID 16849624 in The Annals of pharmacotherapy as Journal Article, Review, with publication-date metadata of 2006-07-18 (day precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-16849624-2026-01-28-bcb767f52eab`](#source-pubmed-observation-pmid-16849624-2026-01-28-bcb767f52eab))

### Paragraph 1

PubMed lists PMID 16849624 in The Annals of pharmacotherapy as Journal Article, Review, with publication-date metadata of 2006-07-18 (day precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-16849624-2026-01-28-bcb767f52eab`](#source-pubmed-observation-pmid-16849624-2026-01-28-bcb767f52eab))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-16849624-2026-01-28-bcb767f52eab`](#source-pubmed-observation-pmid-16849624-2026-01-28-bcb767f52eab))

## Sources

<a id="source-pubmed-observation-pmid-16849624-2026-01-28-bcb767f52eab"></a>
- **Intrathecal ziconotide for refractory chronic pain. · retained source version 1:2026-01-28:current:bcb767f52eab21a3b7329dcd76c535905351b7c5b0c7876ff1379d6005bf22e9** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/16849624/) (`pubmed-observation-pmid-16849624-2026-01-28-bcb767f52eab`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Intrathecal ziconotide for refractory chronic pain." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-16849624-ziconotide-v1.json SHA-256: f6b7ee010cde4bca85531f3983881420cd151121ab2baf374d3e15bab69d9318.